Known targets — ChEMBL curated mechanism
ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO
The experimentally established mechanism targets of Methylene Chloride. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methylene Chloride SCHEMBL6136710 | 1.00 | ALDH1A1 (0.40) | — | |
| Methylene Chloride SCHEMBL4632464 | 1.00 | ALDH1A1 (0.40) | — | |
| Methylene Chloride SCHEMBL5665877 | 1.00 | ALDH1A1 (0.40) | — | |
| Methylene Chloride SCHEMBL365636 | 0.95 | — | — | |
| Methylene Chloride SCHEMBL6270920 | 0.90 | — | — | |
| Water SCHEMBL691249 | 0.84 | TSHR (0.50) | — | |
| Water SCHEMBL5626996 | 0.84 | TSHR (0.50) | — | |
| Water SCHEMBL7675567 | 0.84 | TSHR (0.50) | — | |
| Water SCHEMBL116947 | 0.84 | — | — | |
| Water SCHEMBL6075917 | 0.84 | TSHR (0.50) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1223 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107118219-B | The method of separating-purifying gelsevirine, koumidine, koumine, gelsemine and furans koumine from elegant jessamine | 湖南农业大学 | 2019-03-15 | — | — | CN | claimed |
| US-6432953-B1 | — | — | None | — | — | US | disclosed |
| CN-118215473-A | Method for manufacturing medicine with shortened production time and improved stability | INB博士有限公司 | 2024-06-18 | — | — | CN | disclosed |
| WO-2024106780-A1 | NANOPARTICLE COMPOSITION FOR DRUG DELIVERY | 주식회사 삼양홀딩스 | 2024-05-23 | — | — | WO | disclosed |
| WO-2024096408-A1 | LIPID HAVING AMIDE AND ESTER FUNCTIONAL GROUPS, AND METHOD FOR PRODUCING SAME | 주식회사 삼양홀딩스 | 2024-05-10 | — | — | WO | disclosed |
| WO-2023230472-A1 | INHIBITORS OF MOLLUSCUM CONTAGIOSUM INFECTION AND METHODS USING THE SAME | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2023-11-30 | — | — | WO | disclosed |
| US-20230310645-A1 | NANOPARTICLE COMPOSITION FOR THE DELIVERY OF NUCLEIC ACID AGENTS | TIBA BIOTECH LLC (US) | 2023-10-05 | — | — | US | disclosed |
| EP-3262036-B1 | THERAPEUTIC PYRIDAZINE COMPOUNDS AND USES THEREOF | GENENTECH INC (US) | 2023-09-13 | — | — | EP | disclosed |
| EP-4215182-A1 | DIAMINOPYRIMIDINE P2X3 AND P2X2/3 RECEPTOR MODULATORS FOR USE IN THE TREATMENT OF COUGH | Afferent Pharmaceuticals Inc. (US) | 2023-07-26 | — | — | EP | disclosed |
| WO-2023085567-A1 | METHOD FOR PREPARING MEDICINES, HAVING REDUCED PRODUCTION TIME AND IMPROVED STABILITY | 닥터아이앤비(주) | 2023-05-19 | — | — | WO | disclosed |
| US-4507311-A | Imidazo[1,2-c][1,3]benzodiazepines | CIBA-GEIGY CORPORATION (US) | 1985-03-26 | — | — | US | disclosed |
| US-4497827-A | TETRAZOLE, ACYLHYDROXYLAMINE, HYDROXYMETHYLKETONE AND AMIDE DERIVATIVES | SYNTEX (U.S.A.) INC. (US) | 1985-02-05 | — | — | US | disclosed |
| EP-0132351-A2 | 9-Anthryloxyaminoalkanes and related compounds, processes for their preparation and pharmaceutical compositions containing them | SYNTEX (U.S.A.) INC. (US) | 1985-01-30 | — | — | EP | disclosed |
| EP-0129207-A2 | Substituted phenylalkyl(piperazinyl or homopiperazinyl)-propyl-(ureas or thioureas) | Boehringer Ingelheim Pharmaceuticals Inc. (US) | 1984-12-27 | — | — | EP | disclosed |
| US-4490527-A | Benzo-fused heterocyclic anti-ulcer agents | AMERICAN HOME PRODUCTS CORPORATION (US) | 1984-12-25 | — | — | US | disclosed |
| EP-0122488-A1 | Bis-(piperazinyl- or homopiperazinyl)-alkanes | Boehringer Ingelheim Pharmaceuticals Inc. (US) | 1984-10-24 | — | — | EP | disclosed |
| US-4460587-A | ANTIPSYCHOTIC AGENTS, ANTIALLERGENS | CIBA-GEIGY CORPORATION (US) | 1984-07-17 | — | — | US | disclosed |
| US-4447611-A | ANTISECRETORY AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1984-05-08 | — | — | US | disclosed |
| EP-0104468-A1 | Arachidonic acid analogues as anti-inflammatory and antiallergic agents | SYNTEX (U.S.A.) INC. (US) | 1984-04-04 | — | — | EP | disclosed |
| EP-0081955-A2 | Benzo-fused heterocyclic compounds | AMERICAN HOME PRODUCTS CORPORATION (US) | 1983-06-22 | — | — | EP | disclosed |